Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.
In a four-month randomized trial reported April 30, 2026, 155 Chinese EFL students were split into a control group of 80 and an experimental group of 75 that received robot-assisted language instruction. Questionnaires at the start and end measured classroom engagement and willingness to attend classes.
By April 2026, a peer-reviewed analysis described AI's growing dual role in cyberspace, where it automates anomaly detection, data analysis and incident response to enhance protection, while also enabling cybercriminals to build advanced phishing, deepfakes and hard-to-detect malware.
A peer-reviewed study published March 24, 2026 tested how employees proactively adapt to generative AI at work. Using surveys of 287 employee-leader dyads in China, the authors distinguished approach-oriented AI job crafting aimed at leveraging AI to expand job boundaries from avoidance-oriented crafting aimed at mitigating negative perceptions of AI.
A peer-reviewed study in Sustainability examined FinTech, AI, and Blockchain adoption across G20 countries between 2015 and 2023 to assess links to Sustainable Development Goal outcomes. Using panel methods and macro controls, it found each technology positively associated with national sustainability performance, with AI showing the strongest effect and coordinated use amplifying gains.
On August 13, 2026, a peer-reviewed article in Diagnosis reported results from a two-day workshop of 18 interdisciplinary experts from three countries who sought to identify knowledge gaps in applying AI in clinical settings, using medical imaging as the primary use case.
In a routine-care sample of 1790 patients with major depressive disorder, panic disorder, and social anxiety disorder, researchers built multimodal machine learning models from pretreatment clinical, sociodemographic, and genetic data to predict clinically meaningful improvement after internet-delivered cognitive behavioral therapy, testing them with nested cross-validation and temporal validation in 356 held-out patients as of the August 2026 publication.
A 2026 Perspective in Nature Reviews Drug Discovery reviews a decade of artificial intelligence in drug discovery, asking where advances have translated into safer and more efficacious medicines delivered faster. The authors note many AI methods have been developed, applied and benchmarked, but conclude evidence of clinically relevant impact is so far disappointingly limited.
On 2026-08-07, a peer-reviewed comparative study tested five AI systems including the EAU Guidelines Bot, ChatGPT-5, Gemini 2.5 Pro, Copilot - Smart GPT-5, and Perplexity Pro on 13 questions drawn from strongly recommended EAU erectile dysfunction statements. Three senior reviewers rated each answer for relevance, clarity, structure, clinical utility, and factual accuracy.
ace